Komdigi has launched an identity verification trial using facial recognition technology at GraPARI Graha Merah Putih — a ...
Post-registration trials of Russia's second COVID-19 vaccine are expected to start on Sunday, Deputy Prime Minister Tatiana Golikova said, as authorities urged the population to cancel year-end ...
Brazil's Health Ministry said in a statement on Tuesday that the country would purchase the Pfizer COVID-19 vaccine after it is proven safe in clinical trials and registered with the domestic health ...
The National Agency for Food and Drug Administration and Control has reiterated that no herbal product will receive full ...
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 ...
Limited (“ HUTCHMED ”) (Nasdaq/AIM:?HCM; HKEX:?13) announces results from the FRUSICA-2 registration clinical trial of the fruquintinib and sintilimab combination for the treatment of patients with ...
Viking Therapeutics, Inc. ( NASDAQ: VKTX) Q3 2025 Earnings Call October 22, 2025 4:30 PM EDT Welcome to the Viking Therapeutics Third Quarter 2025 Financial Results Conference Call. [Operator ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has said that herbal medicines will not get full ...
PRAME cell therapy in 16 patients with metastatic uveal melanoma in the ongoing Phase 1b trial continues to show strong ...
Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic diseases with significant unmet medical needs, today ...
The BMJ Group has retracted a study that was published last year about apple cider vinegar and weight loss. The study, which received widespread media attention at the time, claimed drinking diluted ...
ZUG, Switzerland, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic ...